First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer

Dunphy, MPS; Pressl, C; Pillarsetty, N; Grkovski, M; Modi, S; Jhaveri, K; Norton, L; Beattie, BJ; Zanzonico, PB; Zatorska, D; Taldone, T; Ochiana, SO; Uddin, MM; Burnazi, EM; Lyashchenko, SK; Hudis, CA; Bromberg, J; Schoder, HM; Fox, JJ; Zhang, HW; Chiosis, G; Lewis, JS; Larson, SM

Dunphy, MPS (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave,Room S113E, New York, NY 10065 USA.

CLINICAL CANCER RESEARCH, 2020; 26 (19): 5178

Abstract

Purpose: I-124-PU-H71 is an investigational first-in-class radiologic agent specific for imaging tumor epichaperome formations. The intracellular epic......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索